View Post

It’s Time for a Risk-Adapted Approach to Breast Cancer Screening

In In The News by Barbara Jacoby

By: Mahdi Fallah, MD, PhD From: medpagetoday.com A race-based approach has the potential to address disparities in mortality Breast cancer is the second leadingopens in a new tab or window cause of cancer death in women in the U.S., and there is a substantial disparityopens in a new tab or window in breast cancer mortality by race, particularly for early-onset …

View Post

What the FDA Ruling about ‘Dense Breasts’ Means for Cancer Risk and Screening

In In The News by Barbara Jacoby

By: Leah Small From: scientificamerican.com For more than a decade, advocates have pushed for women to be notified if they have “dense” breasts—a factor that not only increases cancer risk but also makes tumors harder to detect on a mammogram. Finally, last month, a long-awaited U.S. Food and Drug Administration ruling determined that after giving patients a mammogram, breast imaging …

View Post

Study finds better breast cancer screening outcomes with tomosynthesis than mammography

In In The News by Barbara Jacoby

Source: Radiological Society of North America From: news-medical.net In a study of over a million women, digital breast tomosynthesis (DBT) showed improved breast cancer screening outcomes over screening with standard digital mammography alone. The results of the study were published in Radiology, a journal of the Radiological Society of North America (RSNA). Breast cancer is the most common cancer among …

View Post

Mammography Screening Intervals and DCIS: What a New Study Reveals

In In The News by Barbara Jacoby

By: Jeff Hall From: diagnosticimaging.com n a new study involving over 900,000 women, researchers found the cumulative six-year risk of mammography screening-detected ductal carcinoma in situ (DCIS) increased with shorter screening intervals and age. s it time to reevaluate mammography screening intervals? In a recently published study in JAMA Network Open, researchers examined mammography screening intervals and six-year cumulative risks …

View Post

Abbreviated MRI can be alternative for breast cancer screening

In In The News by Barbara Jacoby

By: Amerigo Allegretto From: auntminnie.com Abbreviated breast MRI can serve as an alternative to conventional MRI when it comes to high-risk supplemental screening, suggests research presented November 27 at the RSNA annual meeting in Chicago. In her presentation, Dr. Marissa Lawson from the University of Washington in Seattle showed results from her team’s study, which also compared the performances of the …

View Post

Clarifying Expert Recommendations for Breast Cancer Screening

In In The News by Barbara Jacoby

From: nccn.org The National Comprehensive Cancer Network® (NCCN®) has published new NCCN Guidelines for Patients®: Breast Cancer Screening and Diagnosis to help people understand their personal risk for breast cancer, when they should begin screening, and how often to screen—in order to detect cancer earlier, for more treatment options and better outcomes. With this information, they are equipped to have more …

View Post

Digital breast tomosynthesis reduces rate of interval cancers

In Clinical Studies News by Barbara Jacoby

Source: Radiological Society of North America From: eurekalert.org Screening with digital breast tomosynthesis (DBT) reduces the rate of interval breast cancers compared to screening with digital mammography, according to a study published in Radiology. The study adds to a growing body of evidence supporting DBT as a breast cancer screening tool with important advantages over mammography. DBT works by capturing …

View Post

Outcomes by Race in Breast Cancer Screening With Digital Breast Tomosynthesis Versus Digital Mammography

In In The News by Barbara Jacoby

By: DocWire News Featured Reading From: docwirenews.com ABSTRACT PURPOSE: Digital breast tomosynthesis (DBT) in conjunction with digital mammography (DM) is becoming the preferred imaging modality for breast cancer screening compared with DM alone, on the basis of improved recall rates (RR) and cancer detection rates (CDRs). The aim of this study was to investigate racial differences in the utilization and …

View Post

Hologic Receives FDA Clearance for Latest Breakthrough in Early Breast Cancer Detection, Genius AI™ Detection

In In The News by Barbara Jacoby

Source: Hologic, Inc. From: oaoa.com Hologic, Inc. (Nasdaq: HOLX), an innovative medical technology company primarily focused on improving women’s health, today announced U.S. Food and Drug Administration (FDA) clearance and commercial availability of the Company’s Genius AI ™ Detection technology, a new deep learning-based software designed to help radiologists detect subtle potential cancers in breast tomosynthesis images. The new technology …

View Post

Federal Programs Provide Screening and Treatment for Breast and Cervical Cancer

In In The News by Barbara Jacoby

From: gao.gov Tens of thousands of people die each year from breast or cervical cancer. Early screening, detection, and prompt treatment saves lives. The Centers for Disease Control and Prevention’s Early Detection Program provides screening and diagnostic services to low-income and uninsured or underinsured people. States may extend Medicaid to people who aren’t otherwise eligible if they are screened under …